Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05139459 · ClinicalTrials.gov registry record
Sepsis Characterization in Kilimanjaro
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 499
- Enrollment target
NCT05139459 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 499 participants.
The verdict
NCT05139459 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 499 participants
- Enrollment target
Study Summary
The aim of this study is to prospectively evaluate the barriers to care, evaluation, clinical practices, and outcomes for patients presenting with sepsis to hospitals in the Kilimanjaro Region of northern Tanzania. This will include an assessment of timing and selection of antimicrobials and administration and volume of intravenous fluids. The study also aims to characterize sepsis sub-types in the epidemiologic context of northern Tanzania using statistical clustering techniques of clinical variables and of host immune response patterns.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 499 participants |
| Start Date | 2022-01-17 |
| Est. Completion | 2023-11-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05139459
The ClinicalTrials.gov registry entry for NCT05139459 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 499 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05139459 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05139459 about?
NCT05139459 is a clinical study titled "Sepsis Characterization in Kilimanjaro". The aim of this study is to prospectively evaluate the barriers to care, evaluation, clinical practices, and outcomes for patients presenting with sepsis to hospitals in the Kilimanjaro Region of northern Tanzania. This will include an assessment of timing and selection of antimicrobials and adminis...
What is the current status of trial NCT05139459?
This trial is currently completed. The enrollment target is 499 participants. The study started on 2022-01-17. Estimated completion is 2023-11-03.
Who is sponsoring clinical trial NCT05139459?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.